{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T12:06:59Z","timestamp":1784030819089,"version":"3.55.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Investigation"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.resinv.2026.101448","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T10:55:45Z","timestamp":1779274545000},"page":"101448","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Adherence to LAMA\/LABA therapies in middle-aged patients with chronic obstructive pulmonary disease: A group-based trajectory analysis"],"prefix":"10.1016","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-8870-2224","authenticated-orcid":false,"given":"Hao","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7147-0737","authenticated-orcid":false,"given":"Toshiki","family":"Fukasawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6847-9925","authenticated-orcid":false,"given":"Atsushi","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaho","family":"Hirai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8987-4040","authenticated-orcid":false,"given":"Tetsuya","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8400-863X","authenticated-orcid":false,"given":"Kazuhisa","family":"Asai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8460-1456","authenticated-orcid":false,"given":"Takenori","family":"Akaike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satomi","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7477-4071","authenticated-orcid":false,"given":"Koji","family":"Kawakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.resinv.2026.101448_bib1","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.resinv.2023.08.007","article-title":"Management goals and stable phase management of patients with chronic obstructive pulmonary disease in the Japanese respiratory society guideline for the management of chronic obstructive pulmonary disease 2022 (6th edition)","volume":"61","author":"Shibata","year":"2023","journal-title":"Respir Investig"},{"key":"10.1016\/j.resinv.2026.101448_bib2","unstructured":"Global Initiative for Chronic Obstructive Lung Disease. GLOBAL STRATEGY FOR PREVENTION, DIAGNOSIS AND MANAGEMENT OF COPD: 2024 report. https:\/\/goldcopd.org\/2024-gold-report\/[Accessed May 22, 2024]."},{"key":"10.1016\/j.resinv.2026.101448_bib3","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.chest.2016.02.646","article-title":"A systematic review with meta-analysis of dual bronchodilation with LAMA\/LABA for the treatment of stable COPD","volume":"149","author":"Calzetta","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2026.101448_bib4","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.rmed.2013.08.044","article-title":"Clinical and economic impact of non-adherence in COPD: a systematic review","volume":"108","author":"van Boven","year":"2014","journal-title":"Respir Med"},{"key":"10.1016\/j.resinv.2026.101448_bib5","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.rmed.2017.06.007","article-title":"Adherence to COPD treatment: myth and reality","volume":"129","author":"Rogliani","year":"2017","journal-title":"Respir Med"},{"key":"10.1016\/j.resinv.2026.101448_bib6","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.2147\/COPD.S431829","article-title":"Inhaler adherence in COPD: a crucial step towards the correct treatment","volume":"18","author":"Turegano-Yedro","year":"2023","journal-title":"Int J Chronic Obstr Pulm Dis"},{"key":"10.1016\/j.resinv.2026.101448_bib7","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.2147\/COPD.S213520","article-title":"Evaluation of rescue medication use and medication adherence receiving umeclidinium\/vilanterol versus tiotropium bromide\/olodaterol","volume":"14","author":"Moretz","year":"2019","journal-title":"Int J Chronic Obstr Pulm Dis"},{"key":"10.1016\/j.resinv.2026.101448_bib8","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.2147\/COPD.S259850","article-title":"Evaluation of medication adherence and rescue medication use in non-exacerbating patients with COPD receiving umeclidinium\/vilanterol or budesonide\/formoterol as initial maintenance therapy","volume":"15","author":"Moretz","year":"2020","journal-title":"Int J Chronic Obstr Pulm Dis"},{"key":"10.1016\/j.resinv.2026.101448_bib9","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2147\/COPD.S389281","article-title":"Treatment patterns, healthcare utilization and clinical outcomes of patients with chronic obstructive pulmonary disease initiating single-inhaler long-acting beta(2)-Agonist\/Long-Acting muscarinic antagonist dual therapy in primary care in England","volume":"18","author":"Requena","year":"2023","journal-title":"Int J Chronic Obstr Pulm Dis"},{"key":"10.1016\/j.resinv.2026.101448_bib10","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1002\/pds.4334","article-title":"The myths of medication adherence","volume":"26","author":"Gellad","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.resinv.2026.101448_bib11","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/pds.4917","article-title":"Opening the Black box of the group-based trajectory modeling process to analyze medication adherence patterns: an example using real-world statin adherence data","volume":"29","author":"Hickson","year":"2020","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.resinv.2026.101448_bib12","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1097\/MLR.0b013e3182984c1f","article-title":"Group-based trajectory models: a new approach to classifying and predicting long-term medication adherence","volume":"51","author":"Franklin","year":"2013","journal-title":"Med Care"},{"key":"10.1016\/j.resinv.2026.101448_bib13","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1146\/annurev.clinpsy.121208.131413","article-title":"Group-based trajectory modeling in clinical research","volume":"6","author":"Nagin","year":"2010","journal-title":"Annu Rev Clin Psychol"},{"key":"10.1016\/j.resinv.2026.101448_bib14","article-title":"Adherence to single-inhaler triple therapies in middle-aged patients with chronic obstructive pulmonary disease: a group-based trajectory analysis","volume":"64","author":"Liu","year":"2026","journal-title":"Respir Investig"},{"key":"10.1016\/j.resinv.2026.101448_bib15","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/j.rmed.2013.04.005","article-title":"Adherence to inhaled therapies, health outcomes and costs in patients with asthma and COPD","volume":"107","author":"Makela","year":"2013","journal-title":"Respir Med"},{"key":"10.1016\/j.resinv.2026.101448_bib16","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/agm2.12045","article-title":"Factors associated with medication adherence in older patients: a systematic review","volume":"1","author":"Smaje","year":"2018","journal-title":"Aging Med (Milton)"},{"key":"10.1016\/j.resinv.2026.101448_bib17","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1111\/ggi.13115","article-title":"Poor adherence to chronic obstructive pulmonary disease medications in primary care: role of age, disease burden and polypharmacy","volume":"17","author":"Vetrano","year":"2017","journal-title":"Geriatr Gerontol Int"},{"key":"10.1016\/j.resinv.2026.101448_bib18","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.chest.2015.11.025","article-title":"Age-related differences in health-related quality of life in COPD: an analysis of the COPDGene and SPIROMICS cohorts","volume":"149","author":"Martinez","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2026.101448_bib19","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.jamda.2017.09.028","volume":"18","author":"Parulekar","year":"2017","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.resinv.2026.101448_bib20","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01448-2018","article-title":"What is early COPD and why is it important?","volume":"52","author":"Soriano","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2026.101448_bib21","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/jgf2.422","article-title":"Data resource profile: JMDC claims database sourced from health insurance societies","volume":"22","author":"Nagai","year":"2021","journal-title":"J Gen Fam Med"},{"key":"10.1016\/j.resinv.2026.101448_bib22","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2188\/jea.JE20180192","article-title":"Utility of a specific health checkup database containing lifestyle behaviors and lifestyle diseases for employee health insurance in Japan","volume":"30","author":"Fukasawa","year":"2020","journal-title":"J Epidemiol"},{"key":"10.1016\/j.resinv.2026.101448_bib23","doi-asserted-by":"crossref","DOI":"10.37737\/ace.27004","article-title":"From insurance records to epidemiology: provenance and processing of Japanese claims data","author":"Nakao","year":"2026","journal-title":"Annals of Clinical Epidemiology"},{"key":"10.1016\/j.resinv.2026.101448_bib24","doi-asserted-by":"crossref","first-page":"398","DOI":"10.7326\/M18-3079","article-title":"Graphical depiction of longitudinal study designs in health care databases","volume":"170","author":"Schneeweiss","year":"2019","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.resinv.2026.101448_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2024.123092","article-title":"Adherence to istradefylline in patients with parkinson's disease: a group-based trajectory analysis","volume":"462","author":"Fukasawa","year":"2024","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.resinv.2026.101448_bib26","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0103-2023","article-title":"Methods to assess COPD medications adherence in healthcare databases: a systematic review","volume":"32","author":"Vauterin","year":"2023","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.resinv.2026.101448_bib27","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/pds.3787","article-title":"Association between trajectories of statin adherence and subsequent cardiovascular events","volume":"24","author":"Franklin","year":"2015","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.resinv.2026.101448_bib28","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1002\/cpt.865","article-title":"Group-based trajectory models: assessing adherence to antihypertensive medication in older adults in a community pharmacy setting","volume":"103","author":"Dillon","year":"2018","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.resinv.2026.101448_bib29","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.2147\/PPA.S270809","article-title":"Group-based trajectory modeling to identify patterns of adherence and its predictors among older adults on angiotensin-converting enzyme inhibitors (ACEIs)\/Angiotensin receptor blockers (ARBs)","volume":"14","author":"Paranjpe","year":"2020","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.resinv.2026.101448_bib30","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/s12890-021-01612-5","article-title":"Time-to-first exacerbation, adherence, and medical costs among US patients receiving umeclidinium\/vilanterol or tiotropium as initial maintenance therapy for chronic obstructive pulmonary disease: a retrospective cohort study","volume":"21","author":"Slade","year":"2021","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.resinv.2026.101448_bib31","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1177\/1060028016634106","article-title":"Proposal of standardization to assess adherence with medication records: methodology matters","volume":"50","author":"Arnet","year":"2016","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.resinv.2026.101448_bib32","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2147\/COPD.S438893","article-title":"Risk of death and cardiovascular events following an exacerbation of COPD: the EXACOS-CV US study","volume":"19","author":"Daniels","year":"2024","journal-title":"Int J Chronic Obstr Pulm Dis"},{"key":"10.1016\/j.resinv.2026.101448_bib33","doi-asserted-by":"crossref","first-page":"485","DOI":"10.2188\/jea.JE20230285","article-title":"Development and validation of claims-based algorithms for identifying hospitalized patients with COVID-19 and their severity in 2020 and 2021","volume":"34","author":"Ishiguro","year":"2024","journal-title":"J Epidemiol"},{"key":"10.1016\/j.resinv.2026.101448_bib34","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1177\/0049124111400041","article-title":"Group-based trajectory modeling extended to account for nonrandom participant attrition","volume":"40","author":"Haviland","year":"2011","journal-title":"Socio Methods Res"},{"key":"10.1016\/j.resinv.2026.101448_bib35","series-title":"Group-based modeling of development","author":"Nagin","year":"2005"},{"key":"10.1016\/j.resinv.2026.101448_bib36","unstructured":"Jones BL. Traj: group-Based modeling of longitudinal data, (n.d.). https:\/\/www.andrew.cmu.edu\/user\/bjones\/[Accessed May 22, 2024]."},{"key":"10.1016\/j.resinv.2026.101448_bib37","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.2147\/COPD.S411437","article-title":"Comparison of rescue medication prescriptions in patients with chronic obstructive pulmonary disease receiving umeclidinium\/vilanterol versus tiotropium bromide\/olodaterol in routine clinical practice in England","volume":"18","author":"Requena","year":"2023","journal-title":"Int J Chronic Obstr Pulm Dis"},{"key":"10.1016\/j.resinv.2026.101448_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.pupt.2021.102076","article-title":"Which LABA\/LAMA should be chosen in COPD patients in real life?","volume":"71","author":"Sposato","year":"2021","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.resinv.2026.101448_bib39","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12890-025-03563-7","article-title":"Factors associated with low adherence to inhaled therapy in patients with chronic respiratory diseases: a cross-sectional study","volume":"25","author":"Murillo","year":"2025","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.resinv.2026.101448_bib40","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1007\/s11606-012-2130-5","article-title":"Predictors of adherence to inhaled medications among veterans with COPD","volume":"27","author":"Huetsch","year":"2012","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.resinv.2026.101448_bib41","first-page":"414","article-title":"Use patterns of long-acting bronchodilators in routine COPD care: the OUTPUL study","volume":"11","author":"Di Martino","year":"2014","journal-title":"COPD J Chronic Obstr Pulm Dis"},{"key":"10.1016\/j.resinv.2026.101448_bib42","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s41043-024-00715-z","article-title":"Healthcare utilisation patterns and contributory factors among middle-aged adults: a scoping review","volume":"43","author":"Ng","year":"2024","journal-title":"J Health Popul Nutr"},{"key":"10.1016\/j.resinv.2026.101448_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1448986","article-title":"Association between medication complexity and follow-up care attendance: insights from a retrospective multicenter cohort study across 1,223 Chinese hospitals","volume":"15","author":"Ma","year":"2024","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.resinv.2026.101448_bib44","first-page":"547","article-title":"Differences in adherence and non-adherence behaviour patterns to inhaler devices between COPD and asthma patients","volume":"13","author":"Plaza","year":"2016","journal-title":"COPD J Chronic Obstr Pulm Dis"},{"key":"10.1016\/j.resinv.2026.101448_bib45","first-page":"1138","article-title":"Medication adherence trajectories: a systematic literature review","volume":"26","author":"Alhazami","year":"2020","journal-title":"J Manag Care Spec Pharm"},{"key":"10.1016\/j.resinv.2026.101448_bib46","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1080\/09332480.2019.1579578","article-title":"A second chance to get causal inference right: a classification of data science tasks","volume":"32","author":"Hern\u00e1n","year":"2019","journal-title":"Chance"},{"key":"10.1016\/j.resinv.2026.101448_bib48","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11606-014-3029-0","article-title":"Low use and adherence to maintenance medication in chronic obstructive pulmonary disease in the general population","volume":"30","author":"Ingebrigtsen","year":"2015","journal-title":"J Gen Intern Med"}],"container-title":["Respiratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534526000821?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534526000821?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T11:41:14Z","timestamp":1784029274000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212534526000821"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S2212534526000821"],"URL":"https:\/\/doi.org\/10.1016\/j.resinv.2026.101448","relation":{},"ISSN":["2212-5345"],"issn-type":[{"value":"2212-5345","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adherence to LAMA\/LABA therapies in middle-aged patients with chronic obstructive pulmonary disease: A group-based trajectory analysis","name":"articletitle","label":"Article Title"},{"value":"Respiratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resinv.2026.101448","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Japanese Respiratory Society. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101448"}}